Cetera Advisors’s Emergent Biosolutions EBS Stock Holding History

Cetera Advisors’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$428K	Buy	+169,317	New	+$382K	﹤0.01%	1702
2023 Q4	–	Sell	-125,112	Closed	-$425K	–	1813
2023 Q3	$425K	Buy	125,112 +63,774	+104%	+$354K	0.01%	1147
2023 Q2	$451K	Buy	61,338 +50,457	+464%	+$468K	0.01%	1116
2023 Q1	$113K	Buy	+10,881	New	+$132K	﹤0.01%	1552
2020 Q4	–	Sell	-8,379	Closed	-$866K	–	1043
2020 Q3	$866K	Buy	8,379 +106	+1%	+$11.4K	0.03%	407
2020 Q2	$654K	Buy	8,273 +3,436	+71%	+$256K	0.03%	466
2020 Q1	$280K	Buy	+4,837	New	+$279K	0.02%	613

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Cetera Advisors's EBS Position: Q1 2024 in Review

Cetera Advisors opened a new position in Emergent Biosolutions (EBS) in Q1 2024: 169,317 shares worth $428K. The stake represents ﹤0.01% of the portfolio and ranks #1702 among its holdings. This is a return to the name: Cetera Advisors previously reported a position in EBS as recently as Q3 2023.

Cetera Advisors first reported a position in EBS in Q1 2020 and has held it in 7 quarters since. The position peaked at $866K in Q3 2020. 122 funds tracked by Wall St. Rank hold EBS as of Q1 2024.

Cetera Advisors held 169,317 shares of Emergent Biosolutions worth $428K as of Q1 2024.
Emergent Biosolutions was a new Cetera Advisors position in Q1 2024.
Emergent Biosolutions made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #1702 holding.
Cetera Advisors first reported a position in Emergent Biosolutions in Q1 2020 and has held it in 7 quarters since.
Cetera Advisors's Emergent Biosolutions position peaked at $866K in Q3 2020.
122 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.